Periodontal Disease, Inflammatory Cytokines, and PGE2 in Pregnant Patients at Risk of Preterm Delivery: A Pilot Study

Infectious Diseases in Obstetrics and Gynecology
Catalina Latorre UrizaFrancina Maria Escobar Arregoces

Abstract

Periodontal disease is an infection that, in pregnant women, can act as a risk factor for preterm delivery by increasing local and systemic inflammatory responses. Objective. To analyze the presence of periodontal disease, proinflammatory cytokines, and prostaglandin E 2 (PGE2) in pregnant patients at high risk for preterm delivery. Materials and Methods. Pilot study for a case-control study. We included 46 pregnant patients (23 patients at risk of preterm delivery as cases and 23 patients without risk of preterm delivery as controls). We excluded patients who received periodontal treatment, antibiotics, or antimicrobials over the last 3 months as well as those with infections or diseases such as diabetes or hypercholesterolemia. The patients underwent a periodontal assessment, and their levels of cytokines (interleukin- [IL-] 2, IL-6, IL-10, and tumor necrosis factor- [TNF-] α) and prostaglandin E2 (PGE2) were quantified. Results. Patients with periodontal disease showed higher levels of cytokines (IL-2, IL-6, IL-10, and TNF-α) and PGE 2 . Patients at high risk for preterm birth showed higher IL levels compared with patients at low risk for preterm delivery. PGE 2 increased with the severity of periodontal disease. PGE ...Continue Reading

References

Sep 1, 1997·Obstetrics and Gynecology·P C GreigJ Allen
May 22, 1998·Journal of Perinatal Medicine·K J ArntzenR Austgulen
Oct 2, 2004·Obstetrics and Gynecology·Alice R GoepfertJohn C Hauth
Jan 12, 2005·Journal of Clinical Periodontology·Orhun DörtbudakG Rutger Persson
Dec 18, 2012·Periodontology 2000·Gary C Armitage
May 3, 2013·Journal of Clinical Periodontology·Thomas E Van Dyke, Arie Jan van Winkelhoff
May 3, 2013·Journal of Clinical Periodontology·Mariano SanzUNKNOWN Working group 3 of joint EFP/AAP workshop
May 3, 2013·Journal of Clinical Periodontology·Phoebus N MadianosSteven Offenbacher
Feb 11, 2015·International Journal of Applied & Basic Medical Research·Moneet Walia, Navdeep Saini
Nov 2, 2016·The Pan African Medical Journal·Amare Teshome, Asmare Yitayeh
Mar 12, 2017·The Journal of Maternal-fetal & Neonatal Medicine : the Official Journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians·Alberto PuertasFrancisco Mesa
Jun 13, 2017·The Cochrane Database of Systematic Reviews·Zipporah Iheozor-EjioforAnne-Marie Glenny
Aug 30, 2017·International Journal of Women's Health·Charles M CobbRichard J Derman
Mar 24, 2018·Evidence-based Dentistry·Silvia Spivakovsky

❮ Previous
Next ❯

Citations

May 10, 2020·Periodontology 2000·Elena FigueroYasushi Furuichi
Feb 13, 2021·International Journal of Molecular Sciences·Carmen PheifferSumaiya Adam
Dec 11, 2019·Neuroscience and Biobehavioral Reviews·Bogdana Golofast, Karel Vales
Jul 3, 2021·Pathogens·Milan TerzicAntonio Simone Laganà

❮ Previous
Next ❯

Methods Mentioned

BETA
ELISA

Software Mentioned

FCAP Array

Related Concepts

Related Feeds

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.